Actinic Keratosis Treatment Market by Treatment Type (Topical Treatment, Procedural Modality, Photodynamic Therapy and Others), Disease Type (Clinical AK and Subclinical AK) & Region - Forecast 2022-2028
Market Insights on Actinic Keratosis Treatment covering sales outlook, demand forecast and up-to-date key trends
[275 Pages Report] The global Actinic Keratosis Treatment Market was valued at US$ 5.0 Billion in 2021 and is expected to reach US$ 8.0 Billion by 2028, finds Future Market Insights (FMI) in a recent market survey.
Data Points
Market Insights
Market Value 2022
USD 5.4 Billion
Market Value 2028
USD 8.0 Billion
CAGR 2022 to 2028
7.0%
Key Players
The key players are Sun Pharmaceutical Industries Ltd., Biofrontera, Nestle SA, Bausch Health Companies Inc., Novartis AG, GlaxoSmithKline plc., Almirall, LLC, LEO Pharma Inc., Cipher Pharmaceuticals Inc. and Pierre Fabre Pharmaceuticals, Inc.
Share of Top 5 Countries
61.3%
Growing prevalence of actinic keratosis, increase in need for actinic keratosis treatment products, potential drugs in pipeline, and preferable use of topical therapeutics are the primary factors fueling the development of the actinic keratosis treatment market. In addition, the growing incidences of skin cancer, together with the increasing demand for minimally invasive surgeries, is supporting the actinic keratosis treatment market growth.
Also, together with considerable investment in research and development (R&D) activities to manufacture novel therapies with convenient dosage, improved efficacy, and reduced costs, is creating favorable opportunities for the players in the actinic keratosis treatment market.
Actinic Keratosis Treatment market holds nearly 16.6% market value share of the US$ 30 Bn Dermatology Market in 2021. The surgical procedure is expected to be the most preferred for actinic keratosis due to availability of minimally invasive surgeries.
Moreover, new product launches are projected to increase in the forthcoming years as huge number of products are in pipeline for approval for treatment of actinic keratosis.
For instance, in June 2020, Sun Pharmaceutical Industries Ltd. launched Levulan Kerastick, a topical solution for the treatment of mild to moderate actinic keratosis of the scalp, face, and upper extremities
Driven by this, sales of actinic keratosis treatments are expected to rise at a 7.0% CAGR through 2028.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
7.02%
H1, 2022 Projected
6.89%
H1, 2022 Outlook
6.79%
BPS Change - H1, 2022 (O) - H1, 2022 (P)
(-) 10 ↓
BPS Change - H1, 2022 (O) - H1, 2021
(-) 23 ↓
A comparative analysis related to the market growth rates and development prospects in the global actinic keratosis treatment market is presented by Future Market Insights. The market is highly influenced by the regulatory approvals and innovation factors under the impact of macro and industry factors.
The market is subject to developments like, acquisitions and collaborations, wherein the collaborations are mainly done to expand the skin and cosmetic product portfolio.
According to Future Market Insight analysis, the global actinic keratosis treatment market expects to drop by 23 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 Projected value, the market during H1-2022 outlook period will show a dip of 10 BPS.
The advent of the COVID-19 pandemic imposed restrictions upon the general population to be rendered indoors. Owing to this, the lowered exposure to sun has led to a reduction in the occurrence of actinic keratosis, with online distribution channels flourishing as means of proliferation of essential goods.
In developing regions, dearth of skilled professionals and lower treatment adoption rate contribute in negatively impacting the market growth. The lack of awareness in developing regions as well as traditional treatment methods like application of apple cider vinegar can further hamper the market growth.
The actinic keratosis market has the potential to grow during the coming years owing to increasing research & development (R&D) activities to fast track the new drug approvals for the actinic keratosis treatment. Also, the increased risk of developing actinic keratosis associated skin cancer has led to rise in diagnosis & treatment rate.
2013-2021 Actinic Keratosis Treatment Market Demand Outlook Compared to 2022-2028 Forecast
Sales of actinic keratosis treatment grew at a CAGR of 6.6% between 2013 and 2021.
Rising prevalence of actinic keratosis together with rising awareness regarding treatment of the disease and growing adoption of minimally invasive treatments is expected to boost the demand for the actinic keratosis treatment market.
Increasing awareness regarding the adverse effect of actinic keratosis is driving the demand for actinic keratosis treatment. Moreover, awareness campaigns being conducted by government agencies and non-profit organizations is adding considerably to the market development.
For instance, a campaign was launched in 2019 by the Skin Cancer Foundation titled, “Ray Awareness – Preventing Skin Cancer” to boost awareness regarding the tanning beds on the skin as an effect of exposure to UV radiations from the sun while emphasizing actinic keratosis treatment as a primary measure in order to prevent non-melanoma cancer.
The increasing research & development (R&D) activities are anticipated to surge the new drug approvals for the actinic keratosis treatment over the forecast period. Also, the increased risk of developing actinic keratosis associated skin cancer has led to rise in diagnosis & treatment rate.
Considering this, FMI expects the global actinic keratosis treatment market to grow at a CAGR of 7.0% through 2028.
Which Factors Are Restraining Demand for Actinic Keratosis Treatment?
The lack of skilled professionals and low penetration of treatment in developing markets are the major factors hindering the growth of the actinic keratosis treatment market.
Skilled professionals and surgeons are needed for performing actinic keratosis treatment such as chemical peel, cryotherapy, and photodynamic therapy. But, a considerable shortage in the amount of general surgeons is projected to hamper actinic keratosis market development. As per the recent WHO study, there is expected a shortage of around 13 million healthcare professionals across the world by the end of 2035.
In addition, less awareness regarding the health condition in emerging nations and higher treatment costs are expected to restrain growth of the market. Availability of alternative natural treatments is also anticipated to hamper the market growth.
Find your sweet spots for generating winning opportunities in this market.
What is the Impact of the COVID-19 Crisis on the Actinic Keratosis Treatment Market?
The coronavirus is continuously marching across the world, disrupting almost all businesses worldwide. This pandemic outbreak affected industries and several economies because of travel bans, lockdowns, and business closures.
As a consequence of pandemic related lockdowns in several nations and disturbances in the supply chain of medical equipment, the actinic keratosis treatment market observed a drop in sales in 2020.
In 2020, the detection and treatment rates have been decreased considerably because of the limitations on non-essential doctor visits and strict lockdown in many countries. For example, in 2020, about 12.7 million treatments such as topical drugs, photodynamic therapy, and surgical for actinic keratosis were carried out in the U.S. while, in 2019, there were about 15.1 million treatments performed for actinic keratosis.
Country-wise Insights
What Makes the U.S. a Large Market for Actinic Keratosis Treatment?
The U.S. is estimated to account for around 91.5% of the North America Actinic Keratosis Treatment market in 2022.
High prevalence of disease, proactive government measures, rising consumer awareness, and technological advancements are factors contributing to the growth of the market in U.S. As per the American Academy of Dermatology Association, over 40 million Americans suffer from actinic keratosis (AKs) every year. In addition, the availability of well-developed healthcare infrastructure and growing healthcare spending is expected to lead to increase in demand for actinic keratosis treatment in U.S.
Why is U.K. Considered a Lucrative Actinic Keratosis Treatment Market?
U.K. is estimated to account for 27.0% of the Europe actinic keratosis treatment market in Europe in 2022.
The development of the market in U.K. is owing to the high prevalence of actinic keratosis and growing adoption of minimally invasive procedures. In addition, minimally invasive surgeries are first line of treatment for most of the actinic keratosis. Low cost treatment for actinic keratosis together with favorable reimbursements by Medicaid and Medicare are some of the other factors anticipated to boost the demand for the actinic keratosis treatment market and drive the development of the market.
What are the Factors Fueling the Demand for Actinic Keratosis Treatment in Japan?
The actinic keratosis treatment market in Japan is estimated to be worth US$ 145.7 Mn in 2022 in the global market.
Strong reimbursement policies in Japan and large population base over age 40 years are some of the major factors responsible for the growth of the market in Japan. Moreover, high adoption of combination therapies such as topical and cryotherapy are expected to propel the growth of Japan actinic keratosis treatment market.
Actinic keratosis could be eliminated by freezing them together with liquid nitrogen. When the substance is applied, the skin starts healing, as the skin heals, the damaged cells get removed, permitting new skin to appear. Cryotherapy is the most common treatment. Moreover, increasing dermatology visits as growing awareness regarding skin disorder are expected to propel the growth of Japan actinic keratosis market.
How will the Actinic Keratosis Treatment Market Expand across India?
Demand for actinic keratosis treatment in India is expected to rise at around 7.7% CAGR over the forecast period.
The growing patient pool affected from actinic keratosis, increasing per capita healthcare expenditure and increasing R&D funding for novel therapies is expected to be the primary factors fueling the development of the actinic keratosis treatment market in India. Moreover, rising geriatric population India that is highly prone to actinic keratosis is one of the major factors driving the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Demand for Topical Treatment to continue gaining Traction
By treatment type, topical treatment is anticipated to hold the maximum share of 46.9% in 2022, expanding at rate of nearly 6.2% during the forecast period.
Growing adoption of self-administered treatment and easy availability of home-based therapy options is expected to drive the growth of the segment. Topical creams comprising fluorouracil that is a chemotherapy drug, and other medicines such as Imiquimod (INN) gels and diclofenac which is an analgesic, are mostly prescribed as topical treatment for actinic keratosis. The combined treatment of cryotherapy and fluorouracil with the help of cryosurgery units is also adopted due to its great success rate in treatment of actinic keratosis.
Why Clinical Actinic Keratosis will hold the most of the market share?
By disease type, clinical actinic keratosis will lead the market and is projected to account for 95.2% of the total market revenue share in 2022.
The growing prevalence of clinical actinic keratosis is the primary factor driving the segment growth. While the occurrence of actinic keratosis is growing, awareness regarding the risk of disease leading to the development of a cancer is convincing dermatologists for more clinical diagnosis. Rising awareness regarding the risk of clinical actinic keratosis lesions is expected to add to the development of the segment over the forecast period.
Why Hospitals projected maximum growth in the Actinic Keratosis Treatment Market?
By end user, the hospitals segment is anticipated to hold the maximum share of 34.0% in 2022, expanding at rapid rate of 6.4% CAGR during the forecast period.
The ease of accessibility of patient pool in hospitals owing to the availability of required therapies and medications at a single place is a primary factor adding towards the highest share of the segment. In addition, developing healthcare infrastructure, high adoption of surgical procedures and growing adoption of photodynamic therapy is expected to drive the growth of the actinic keratosis treatment market.
Competitive Landscape
Companies operating in the actinic keratosis treatment market are consolidated and competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:
In December 2020, Almirall, S.A. received the U.S. FDA approval for Klisyri (tirbanibulin) for the treatment of actinic keratosis of the face and scalp.
In April 2020, Biofrontera signed an exclusive agreement with Maruho Co., Ltd. in Japan for the development and commercialization of Ameluz, medicine used in adults to treat mild to moderate actinic keratosis in the Asia Pacific region.
Scope Of The Report
Attribute
Details
Forecast Period
2013 to 2021
Historical Data Available for
2022 to 2028
Market Analysis
USD Million for Value
Key Countries Covered
USA, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Russia, Poland, China, Japan, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa
The actinic keratosis treatment market may reach a valuation of US$ 8.0 billion by 2028.
Topical is the preferred treatment type, with a value share of 6.2% by 2028.
Clinical Actinic Keratosis is the leading disease type in the market.
Increasing use of tropical fluorouracil, diclofenac, and cryotherapy among others may drive market growth over the coming years.
India, Japan, and China are the Asian countries in actinic keratosis treatment market.
The United States is leading in the actinic keratosis treatment market.
Substantial investment to create novel medicines at lower prices may provide growth prospects for the market players.
Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
2.3. Exclusion and Inclusion
3. Global Economic Outlook
3.1. Gross Domestic Product by Region & Country, 2006 – 2021
3.2. Global Healthcare Market Indicators
4. Market Opportunity Analysis
4.1. Macro-Economic Factors
4.2. Opportunity Analysis
5. Market Dynamics
5.1. Drivers
5.1.1. Supply Side Drivers
5.1.2. Demand Side Drivers
5.2. Restraints
5.3. Trends
6. Market Data Call Out
6.1. Parent Market Analysis
6.2. Disease Epidemiology
6.3. Treatment Regimen
6.4. Procedure Volume of Cosmetic Therapies
6.5. Key Regulations
6.6. Reimbursement Scenario and Payer Mix Analysis
6.7. Treatment Cost by Region
7. North America Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
7.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021
7.4.1. Topical Treatment
7.4.1.1. 5-fluorouracil Cream
7.4.1.2. Diclofenac Gel
7.4.1.3. Imiquimod Cream
7.4.1.4. Ingenol mebutate Gel
7.4.2. Procedural Modality
7.4.2.1. Chemical Peels
7.4.2.2. Cryotherapy
7.4.3. Photodynamic Therapy
7.4.4. Others
7.5. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028
7.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021
7.6.1. Clinical AK
7.6.2. Subclinical AK
7.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
7.8.1. Hospitals
7.8.2. Private Dermatology Clinics
7.8.3. Laser Therapy Centers
7.8.4. Cancer Treatment Centers
7.8.5. Spas and Rejuvenation Centers
7.8.6. Homecare
7.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Treatment Type
7.10.3. By Disease Type
7.10.4. By End User
7.11. Drivers and Restraints: Impact Analysis
7.12. Key Market Participants – Intensity Mapping
8. Latin America Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028
8.1. Introduction
8.2. Regional Market Trends
8.3. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021
8.3.1. Brazil
8.3.2. Mexico
8.3.3. Rest of Latin America
8.4. Market Size (US$ Mn) Forecast By Country, 2022–2028
8.5. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021
8.5.1. Topical Treatment
8.5.1.1. 5-fluorouracil Cream
8.5.1.2. Diclofenac Gel
8.5.1.3. Imiquimod Cream
8.5.1.4. Ingenol mebutate Gel
8.5.2. Procedural Modality
8.5.2.1. Chemical Peels
8.5.2.2. Cryotherapy
8.5.3. Photodynamic Therapy
8.5.4. Others
8.6. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028
8.7. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021
8.7.1. Clinical AK
8.7.2. Subclinical AK
8.8. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
8.9.1. Hospitals
8.9.2. Private Dermatology Clinics
8.9.3. Laser Therapy Centers
8.9.4. Cancer Treatment Centers
8.9.5. Spas and Rejuvenation Centers
8.9.6. Homecare
8.10. Market Size (US$ Mn) Forecast By End User, 2022–2028
8.11. Market Attractiveness Analysis
8.11.1. By Country
8.11.2. By Treatment Type
8.11.3. By Disease Type
8.11.4. By End User
8.12. Drivers and Restraints: Impact Analysis
8.13. Key Market Participants – Intensity Mapping
9. Western Europe Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021
9.2.1. Germany
9.2.2. U.K
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Western Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
9.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021
9.4.1. Topical Treatment
9.4.1.1. 5-fluorouracil Cream
9.4.1.2. Diclofenac Gel
9.4.1.3. Imiquimod Cream
9.4.1.4. Ingenol mebutate Gel
9.4.2. Procedural Modality
9.4.2.1. Chemical Peels
9.4.2.2. Cryotherapy
9.4.3. Photodynamic Therapy
9.4.4. Others
9.5. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028
9.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021
9.6.1. Clinical AK
9.6.2. Subclinical AK
9.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
9.8.1. Hospitals
9.8.2. Private Dermatology Clinics
9.8.3. Laser Therapy Centers
9.8.4. Cancer Treatment Centers
9.8.5. Spas and Rejuvenation Centers
9.8.6. Homecare
9.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
9.10. Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Treatment Type
9.10.3. By Disease Type
9.10.4. By End User
9.11. Drivers and Restraints: Impact Analysis
9.12. Key Market Participants – Intensity Mapping
10. Eastern Europe Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021
10.2.1. Russia
10.2.2. Poland
10.2.3. Rest of Eastern Europe
10.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
10.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021
10.4.1. Topical Treatment
10.4.1.1. 5-fluorouracil Cream
10.4.1.2. Diclofenac Gel
10.4.1.3. Imiquimod Cream
10.4.1.4. Ingenol mebutate Gel
10.4.2. Procedural Modality
10.4.2.1. Chemical Peels
10.4.2.2. Cryotherapy
10.4.3. Photodynamic Therapy
10.4.4. Others
10.5. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028
10.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021
10.6.1. Clinical AK
10.6.2. Subclinical AK
10.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
10.8.1. Hospitals
10.8.2. Private Dermatology Clinics
10.8.3. Laser Therapy Centers
10.8.4. Cancer Treatment Centers
10.8.5. Spas and Rejuvenation Centers
10.8.6. Homecare
10.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Treatment Type
10.10.3. By Disease Type
10.10.4. By End User
10.11. Drivers and Restraints: Impact Analysis
10.12. Key Market Participants – Intensity Mapping
11. Asia Pacific Excluding Japan Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021
11.2.1. India
11.2.2. Australia and New Zealand
11.2.3. China
11.2.4. ASEAN
11.2.5. Rest of APECJ
11.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
11.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021
11.4.1. Topical Treatment
11.4.1.1. 5-fluorouracil Cream
11.4.1.2. Diclofenac Gel
11.4.1.3. Imiquimod Cream
11.4.1.4. Ingenol mebutate Gel
11.4.2. Procedural Modality
11.4.2.1. Chemical Peels
11.4.2.2. Cryotherapy
11.4.3. Photodynamic Therapy
11.4.4. Others
11.5. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028
11.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021
11.6.1. Clinical AK
11.6.2. Subclinical AK
11.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
11.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
11.8.1. Hospitals
11.8.2. Private Dermatology Clinics
11.8.3. Laser Therapy Centers
11.8.4. Cancer Treatment Centers
11.8.5. Spas and Rejuvenation Centers
11.8.6. Homecare
11.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
11.10. Market Attractiveness Analysis
11.10.1. By Country
11.10.2. By Treatment Type
11.10.3. By Disease Type
11.10.4. By End User
11.11. Drivers and Restraints: Impact Analysis
11.12. Key Market Participants – Intensity Mapping
12. Japan Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021
12.2.1. Topical Treatment
12.2.1.1. 5-fluorouracil Cream
12.2.1.2. Diclofenac Gel
12.2.1.3. Imiquimod Cream
12.2.1.4. Ingenol mebutate Gel
12.2.2. Procedural Modality
12.2.2.1. Chemical Peels
12.2.2.2. Cryotherapy
12.2.3. Photodynamic Therapy
12.2.4. Others
12.3. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028
12.4. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021
12.4.1. Clinical AK
12.4.2. Subclinical AK
12.5. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
12.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
12.6.1. Hospitals
12.6.2. Private Dermatology Clinics
12.6.3. Laser Therapy Centers
12.6.4. Cancer Treatment Centers
12.6.5. Spas and Rejuvenation Centers
12.6.6. Homecare
12.7. Market Size (US$ Mn) Forecast By End User, 2022–2028
12.8. Market Attractiveness Analysis
12.8.1. By Country
12.8.2. By Treatment Type
12.8.3. By Disease Type
12.8.4. By End User
12.9. Drivers and Restraints: Impact Analysis
12.10. Key Market Participants – Intensity Mapping
13. Middle East and Africa Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2021
13.2.1. GCC Countries
13.2.2. South Africa
13.2.3. Rest of Middle East and Africa
13.3. Market Size (US$ Mn) Forecast By Country, 2022–2028
13.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Type, 2013–2021
13.4.1. Topical Treatment
13.4.1.1. 5-fluorouracil Cream
13.4.1.2. Diclofenac Gel
13.4.1.3. Imiquimod Cream
13.4.1.4. Ingenol mebutate Gel
13.4.2. Procedural Modality
13.4.2.1. Chemical Peels
13.4.2.2. Cryotherapy
13.4.3. Photodynamic Therapy
13.4.4. Others
13.5. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028
13.6. Historical Market Size (US$ Mn) Trend Analysis By Disease Type, 2013–2021
13.6.1. Clinical AK
13.6.2. Subclinical AK
13.7. Market Size (US$ Mn) Forecast By Disease Type, 2022–2028
13.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2021
13.8.1. Hospitals
13.8.2. Private Dermatology Clinics
13.8.3. Laser Therapy Centers
13.8.4. Cancer Treatment Centers
13.8.5. Spas and Rejuvenation Centers
13.8.6. Homecare
13.9. Market Size (US$ Mn) Forecast By End User, 2022–2028
13.10. Market Attractiveness Analysis
13.10.1. By Country
13.10.2. By Treatment Type
13.10.3. By Disease Type
13.10.4. By End User
13.11. Drivers and Restraints: Impact Analysis
13.12. Key Market Participants – Intensity Mapping
14. Forecast Factors: Relevance and Impact15. Forecast Assumptions16. Market Structure Analysis
16.1. Market Structure by Tier
16.2. Brand Share Analysis (2021) for Photodynamic Therapy
16.3. Product Intensity Mapping by Manufacturer
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competitors Deep Dive
17.2.1. Sun Pharmaceutical Industries Ltd.
17.2.2. Biofrontera
17.2.3. Nestle SA
17.2.4. Bausch Health Companies Inc.
17.2.5. Novartis AG
17.2.6. GlaxoSmithKline plc.
17.2.7. Almirall, LLC
17.2.8. LEO Pharma Inc.
17.2.9. Cipher Pharmaceuticals Inc
17.2.10. Pierre Fabre Pharmaceuticals, Inc.
18. Global Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028 By Region
18.1. Introduction / Key Findings
18.2. Historical Market Size (US$ Mn) Analysis By Region
18.2.1. North America
18.2.2. Latin America
18.2.3. Western Europe
18.2.4. Eastern Europe
18.2.5. Asia Pacific Excluding Japan
18.2.6. Japan
18.2.7. Middle East and Africa
18.3. Market Size (US$ Mn) Forecast By Region
18.4. Market Attractiveness Analysis By Region
19. Global Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
19.1. Introduction/Key Finding
19.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2013–2021
19.2.1. Topical Treatment
19.2.1.1. 5-fluorouracil Cream
19.2.1.2. Diclofenac Gel
19.2.1.3. Imiquimod Cream
19.2.1.4. Ingenol mebutate Gel
19.2.2. Procedural Modality
19.2.2.1. Chemical Peels
19.2.2.2. Cryotherapy
19.2.3. Photodynamic Therapy
19.2.4. Others
19.3. Market Size (US$ Mn) Forecast By Treatment Type, 2022–2028
19.4. Market Attractiveness Analysis By Treatment Type
20. Global Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By End User
20.1. Introduction/Key Finding
20.2. Historical Market Size (US$ Mn) Analysis By End User, 2013–2021
20.2.1. Clinical AK
20.2.2. Subclinical AK
20.3. Market Size (US$ Mn) Forecast By End User, 2022–2028
20.4. Market Attractiveness Analysis By End User
21. Global Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028, By End User
21.1. Introduction/Key Finding
21.2. Historical Market Size (US$ Mn) Analysis By End User, 2013–2021
21.2.1. Hospitals
21.2.2. Private Dermatology Clinics
21.2.3. Laser Therapy Centers
21.2.4. Cancer Treatment Centers
21.2.5. Spas and Rejuvenation Centers
21.2.6. Homecare
21.3. Market Size (US$ Mn) Forecast By End User, 2022–2028
21.4. Market Attractiveness Analysis By End User
22. Global Actinic Keratosis Treatment Market Analysis 2013–2021 and Forecast 2022–2028
22.1. Market Value Analysis (US$ Mn)
22.2. Absolute $ Opportunity
23. Assumptions and Acronyms Used24. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 – 2021 (1/2)
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 – 2021 (2/2)
Table 03: Prescription Pattern for Actinic Keratosis Treatment
Table 04: Outlook of Interval and Combination Therapies in Actinic Keratosis Treatment (1/2)
Table 05: Outlook of Interval and Combination Therapies in Actinic Keratosis Treatment (2/2)
Table 06: Procedure Volume of Non-invasive/Minimally Invasive Cosmetic Therapies By Major Countries (2016) (1/2)
Table 07: Procedure Volume of Non-invasive/Minimally Invasive Cosmetic Therapies By Major Countries (2016) (2/2)
Table 08: CPT code for Actinic Keratosis Treatment (1/4)
Table 09: CPT code for Actinic Keratosis Treatment (2/4)
Table 10: CPT code for Actinic Keratosis Treatment (3/4)
Table 11: CPT code for Actinic Keratosis Treatment (4/4)
Table 12: HCPCS code for Actinic Keratosis Treatment
Table 13: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country
Table 14: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Table 15: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type
Table 16: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User
Table 17: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country
Table 18: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Table 19: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type
Table 20: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User
Table 21: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country
Table 22: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Table 23: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type
Table 24: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User
Table 25: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country
Table 26: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Table 27: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type
Table 28: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User
Table 29: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country
Table 30: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Table 31: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type
Table 32: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User
Table 33: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Table 34: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type
Table 35: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User
Table 36: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Country
Table 37: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Table 38: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Disease Type
Table 39: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By End User
Table 40: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Region
Table 41: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Treatment Type
Table 42: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By Disease Type
Table 43: Global Actinic Keratosis Treatment Market Value (US$ Mn) Analysis- and Opportunity Assessment 2013–2028, By End User
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 02: Prevalence Of Actinic Keratosis Among Male in Different Degree of Latitude
Figure 03: Prevalence Of Actinic Keratosis Among Female in Different Degree of Latitude
Figure 04: Global Dermatology Market Overview
Figure 05: Payer Mix Analysis – U.S.
Figure 06: Photo Dynamic Therapy Per Session Cost (US$), By Region (2021)
Figure 07: Chemical Peel Procedure Per Session Cost (US$), By Region (2021)
Figure 08: Cryotherapy Procedure Cost (US$), By Region (2021)
Figure 09: Topical Treatment Cost (US$), By Region (2021)
Figure 10: North America Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)
Figure 11 : North America Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)
Figure 12: North America Actinic Keratosis Treatment Market Value Share By End User (2022 E)
Figure 13: North America Actinic Keratosis Treatment Market Value Share By Country (2022 E)
Figure 14: North America Actinic Keratosis Treatment Market Value Analysis
Figure 15: North America Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 16: U.S. Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 17: U.S. Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 18: Canada Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 19: Canada Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 20: North America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Figure 21: North America Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028
Figure 22: North America Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028
Figure 23: North America Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028
Figure 24: North America Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028
Figure 25 : Latin America Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)
Figure 26: Latin America Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)
Figure 27: Latin America Actinic Keratosis Treatment Market Value Share By End User (2022 E)
Figure 28: Latin America Actinic Keratosis Treatment Market Value Share By Country (2022 E)
Figure 29: Latin America Actinic Keratosis Treatment Market Value Analysis
Figure 30: Latin America Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 31: Brazil Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 32: Brazil Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 33: Mexico Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 34: Mexico Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 35: Rest of Latin America Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 36: Rest of Latin America Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 37: Latin America Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Figure 38: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028
Figure 39: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028
Figure 40: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028
Figure 41: Latin America Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028
Figure 42: Western Europe Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)
Figure 43: Western Europe Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)
Figure 44: Western Europe Actinic Keratosis Treatment Market Value Share By End User (2022 E)
Figure 45: Western Europe Actinic Keratosis Treatment Market Value Share By Country (2022 E)
Figure 46: Western Europe Actinic Keratosis Treatment Market Value Analysis
Figure 47: Western Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 48: U.K. Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 49: U.K. Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 50: Germany Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
Figure 51: Germany Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 52: France Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 53: France Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 54: Italy Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
Figure 55: Italy Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 56: Spain Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 57: Spain Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 58: Rest of Western Europe Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
Figure 59: Rest of Western Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 60: Western Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Figure 61: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028
Figure 62: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028
Figure 63: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028
Figure 64: Western Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028
Figure 65: Eastern Europe Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)
Figure 66: Eastern Europe Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)
Figure 67: Eastern Europe Actinic Keratosis Treatment Market Value Share By End User (2022 E)
Figure 68: Eastern Europe Actinic Keratosis Treatment Market Value Share By Country (2022 E)
Figure 69: Eastern Europe Actinic Keratosis Treatment Market Value Analysis
Figure 70: Eastern Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 71: Russia Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 72: Russia Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 73: Poland Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 74: Poland Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 75: Rest of Eastern Europe Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 76: Rest of Eastern Europe Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 77: Eastern Europe Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Figure 78: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028
Figure 79: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028
Figure 80: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028
Figure 81: Eastern Europe Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028
Figure 82: APEJ Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)
Figure 83: APEJ Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)
Figure 84: APEJ Actinic Keratosis Treatment Market Value Share By End User (2022 E)
Figure 85: APEJ Actinic Keratosis Treatment Market Value Share By Country (2022 E)
Figure 86: APEJ Actinic Keratosis Treatment Market Value Analysis
Figure 87: APEJ Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 88: India Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 89: India Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 90: Australia & NZ Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
Figure 91: Australia & NZ Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 92: China Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 93: China Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 94: ASEAN Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
Figure 95: ASEAN Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 96: Rest of APEJ Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 97: Rest of APEJ Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 98: APEJ Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Figure 99: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028
Figure 100: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028
Figure 101: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028
Figure 102: APEJ Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028
Figure 103: Japan Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)
Figure 104: Japan Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)
Figure 105: Japan Actinic Keratosis Treatment Market Value Share By End User (2022 E)
Figure 106: Japan Actinic Keratosis Treatment Market Value Analysis
Figure 107: Japan Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 108: Japan Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Figure 109: Japan Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028
Figure 110: Japan Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028
Figure 111: Japan Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028
Figure 112: MEA Actinic Keratosis Treatment Market Value Share By Treatment Type (2022 E)
Figure 113: MEA Actinic Keratosis Treatment Market Value Share By Disease Type (2022 E)
Figure 114: MEA Actinic Keratosis Treatment Market Value Share By End User (2022 E)
Figure 115: MEA Actinic Keratosis Treatment Market Value Share By Country (2022 E)
Figure 116: MEA Actinic Keratosis Treatment Market Value Analysis
Figure 117: MEA Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 118: South Africa Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 119: South Africa Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 120: GCC Countries Actinic Keratosis Treatment Market Value Analysis (US$ Mn),
Figure 121: GCC Countries Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 122: Rest of MEA Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 123: Rest of MEA Actinic Keratosis Treatment Market Value Forecast (US$ Mn), 2022–2028
Figure 124: MEA Actinic Keratosis Treatment Market Value (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Treatment Type
Figure 125: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028
Figure 126: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028
Figure 127: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028
Figure 128: MEA Actinic Keratosis Treatment Market Attractiveness Analysis by Country, 2022–2028
Figure 129: Global Photodynamic Therapy Market: Brand Share Analysis Share Analysis (2021)
Figure 130: Global Actinic Keratosis Treatment Market Share Analysis (%), By Region, 2022 & 2028
Figure 131: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By Region, 2022–2028
Figure 132: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Region, 2022–2028
Figure 133: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Region, 2022–2028
Figure 134: Global Actinic Keratosis Treatment Market Share Analysis (%), By Treatment Type, 2022 & 2028
Figure 135: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By Treatment Type, 2022–2028
Figure 136: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Treatment Type, 2022–2028
Figure 137: Global Actinic Keratosis Treatment Market Share Analysis (%), By Disease Type, 2022 & 2028
Figure 138: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By Disease Type, 2022–2028
Figure 139: Global Actinic Keratosis Treatment Market Attractiveness Analysis by Disease Type, 2022–2028
Figure 140: Global Actinic Keratosis Treatment Market Share Analysis (%), By End User, 2022 & 2028
Figure 141: Global Actinic Keratosis Treatment Market Y-o-Y Analysis (%), By End User, 2022–2028
Figure 142: Global Actinic Keratosis Treatment Market Attractiveness Analysis by End User, 2022–2028
Figure 143: Global Actinic Keratosis Treatment Market Value Analysis (US$ Mn), 2013–2021
Figure 144: Global Actinic Keratosis Treatment Market Value Forecast (US$ Mn),
Figure 145: Global Actinic Keratosis Treatment Market Absolute $ Opportunity, 2022–2028
